Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 19, Number 14, 2013

Articles

Editorial (Hot Topic: Flavoproteins and Flavoenzymes with Biomedical and Therapeutic Impact)
pp. 2497-2498(2)
Authors: Medina, Milagros; Ferreira, Patricia; Martinez-Julvez, Marta

Favourites:
ADD

D-Amino Acid Oxidase Inhibitors as a Novel Class of Drugs for Schizophrenia Therapy
pp. 2499-2511(13)
Authors: Sacchi, Silvia; Rosini, Elena; Pollegioni, Loredano; Molla, Gianluca

Favourites:
ADD

1,4-Naphthoquinones and Other NADPH-Dependent Glutathione Reductase- Catalyzed Redox Cyclers as Antimalarial Agents
pp. 2512-2528(17)
Authors: Belorgey, Didier; Antoine Lanfranchi, Don; Davioud-Charvet, Elisabeth

Favourites:
ADD

Inhibitor Design for Monoamine Oxidases
pp. 2529-2539(11)
Author: R. Ramsay, Rona

Favourites:
ADD

Is Renalase a Novel Player in Catecholaminergic Signaling? The Mystery of the Catalytic Activity of an Intriguing New Flavoenzyme
pp. 2540-2551(12)
Authors: Baroni, Sara; Milani, Mario; Pandini, Vittorio; Pavesi, Giulio; Horner, David; Aliverti, Alessandro

Favourites:
ADD

Riboflavin Analogs as Antiinfectives: Occurrence, Mode of Action, Metabolism and Resistance
pp. 2552-2560(9)
Authors: Biscaro Pedrolli, Danielle; Jankowitsch, Frank; Schwarz, Julia; Langer, Simone; Nakanishi, Shinobu; Frei, Eva; Mack, Matthias

Favourites:
ADD

Open Access Targeting UDP-Galactopyranose Mutases from Eukaryotic Human Pathogens
pp. 2561-2573(13)
Authors: Kizjakina, Karina; J. Tanner, John; Sobrado, Pablo

Favourites:
ADD
Favourites:
ADD

Redox Proteins as Targets for Drugs Development Against Pathogens
pp. 2594-2605(12)
Authors: L. Catalano-Dupuy, Daniela; Lopez-Rivero, Arleth; Soldano, Anabel; A. Ceccarelli, Eduardo

Favourites:
ADD

Open Access Chemical Nature and Reaction Mechanisms of the Molybdenum Cofactor of Xanthine Oxidoreductase
pp. 2606-2614(9)
Authors: Okamoto, Ken; Kusano, Teruo; Nishino, Takeshi

Favourites:
ADD

Target Sites for the Design of Anti-trypanosomatid Drugs Based on the Structure of Dihydroorotate Dehydrogenase
pp. 2615-2627(13)
Authors: Pinto Pinheiro, Matheus; da Silva Emery, Flavio; Cristina Nonato, M.

Favourites:
ADD

The Oxido-reductase Activity of the Apoptosis Inducing Factor: A Promising Pharmacological Tool?
pp. 2628-2636(9)
Authors: Ferreira, Patricia; Villanueva, Raquel; Cabon, Lauriane; A. Susin, Santos; Medina, Milagros

Favourites:
ADD

The Prokaryotic FAD Synthetase Family: A Potential Drug Target
pp. 2637-2648(12)
Authors: Serrano, Ana; Ferreira, Patricia; Martinez-Julvez, Marta; Medina, Milagros

Favourites:
ADD

Biosynthesis of Flavin Cofactors in Man: Implications in Health and Disease
pp. 2649-2675(27)
Authors: Barile, Maria; Anna Giancaspero, Teresa; Brizio, Carmen; Panebianco, Concetta; Indiveri, Cesare; Galluccio, Michele; Vergani, Lodovica; Eberini, Ivano; Gianazza, Elisabetta

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content